HCPCS Level II
Q5107
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
Codes near Q5107
These sit next to Q5107 in the CMS Level II file. All Q codes
- Q5102Injection, infliximab, biosimilar, 10 mg
- Q5103Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
- Q5104Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
- Q5105Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
- Q5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
- Q5108Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
- Q5109Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
- Q5110Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
- Q5111Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
- Q5112Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 55513-0206-01 | Mvasi | Amgen Inc | 10 |
| 55513-0206-21 | Mvasi | Amgen Inc | 10 |
| 55513-0207-01 | Mvasi | Amgen Inc | 40 |
| 55513-0207-21 | Mvasi | Amgen Inc | 40 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.